IP Library Granted Patent US 11,865,299
Granted Patent B2
US 11,865,299 · App. 16/947,627 · Granted Jan 9, 2024

Infusion pump systems and methods

Inventor: Mark C. Estes (Malibu, CA)
Assignee: Insulet Corporation
A61M5/1413A61M5/1456A61M5/14244A61M5/1723G16H20/17A61M5/14248A61M2005/14208A61M2005/14268A61M2202/0007A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,865,299
App. No.
16/947,627
Granted
Jan 9, 2024
Kind
B2
Abstract

Some embodiments of an infusion pump system can be used to determine a user's total insulin load (TIL) that provides an accurate indication of the insulin previously delivered to the user's body which has not yet acted. In particular embodiments, the TIL can account for both the bolus deliveries and the basal deliveries that have occurred over a period of time. Such information may be useful, for example, when the infusion pump is operated in conjunction with a continuous glucose monitoring device.

Claims (23)

1. A system, comprising:

a pump housing that receives insulin for dispensation to a user, the pump housing at least partially containing a pump drive system to dispense insulin through a flow path to the user;

a controller that instructs the pump drive system to dispense the insulin from the pump housing, wherein the controller is configured to receive glucose information being indicative of a glucose level of the user; and

an external computer including a display in wireless communication with the controller,

wherein the system determines a total insulin load according to a function that accounts for a bolus insulin load and a basal insulin load, and calculates future glucose level of the user, and

wherein the total insulin load is a normalized total insulin load (TIL) percentage value and the system utilizes the normalized TIL percentage value to calculate the future glucose level of the user.

2. The system of claim 1 , wherein the function further accounts for a previous food component based upon previous food intake that has not yet metabolized in the user.

3. The system of claim 1 , wherein the system displays to a user a glucose value indicative of the glucose level of the user and the total insulin load.

4. The system of claim 3 , wherein the glucose value and the total insulin load are contemporaneously displayed to the user.

5. The system of claim 1 , wherein the total insulin load is determined by the controller.

6. The system of claim 1 , further comprising a computer-readable memory device coupled to the controller that stores one or more calculated values for the total insulin load and one or more corresponding time values.

7. The system of claim 1 , wherein the controller comprises a controller housing that removably attaches to the pump housing, the controller being electrically connected to the pump drive system when the controller housing is removably attached to the pump housing.

8. The system of claim 1 , wherein the controller is a reusable device, and wherein the pump housing and pump drive system are components of a disposable and nonreusable pump device having one or more structures that hinder reuse of the pump device after a supply of the insulin is exhausted.

9. The system of claim 1 , wherein the pump housing receives a prefilled cartridge through an opening of the pump housing that is coverable with a cap device.

10. The system of claim 9 , wherein the flow path of the insulin comprises an infusion set tube that extends from the cap device to the user.

11. The system of claim 1 , wherein the total insulin load is determined based on a user input request.

12. The system of claim 1 , wherein the total insulin load is automatically determined at predetermined intervals.

13. The system of claim 1 , wherein the normalized total insulin load (TIL) percentage value is determined according to the function:

total insulin load percentage=[(Actual TIL)−(theoretical TIL basal )]/(theoretical TIL basal )×100

where theoretical TIL basal represents the TIL that would have been generated based only on the user's basal insulin dosages.

14. The system of claim 1 , wherein the system alerts the user when the total insulin load is a negative value.

15. The system of claim 1 , wherein the system alerts the user when the total insulin load increases at a rate above a predetermined rate indicative of a potentially unsafe condition.

16. The system of claim 1 , wherein the total insulin load is a numerical value that is displayed to the user.

Assignments (15)
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY AGREEMENT SUPPLEMENT Recorded Sep 7, 2023
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 064840/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2023
From: BIGFOOT BIOMEDICAL, INC.
To: INSULET CORPORATION
Reel/Frame 062900/0001 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 062793/0316 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
Continuity (6)
Continuation 15948356 · Apr 9, 2018
Continuation 14797400 · Jul 13, 2015
Continuation 13524200 · Jun 15, 2012
Continuation 13071061 · Mar 24, 2011
Division 12195034 · Aug 20, 2008
Related Publication 20200368426A1 · Nov 26, 2020
Cited By (9)
US 12,268,656 US 12,280,014 US 12,322,487 US 12,347,541 US 12,409,279 US 12,478,558 US 12,482,546 US 12,512,200 US 12,697,285